RxDoctor Payments Data

Alexis Huss, PA

Physician Assistant · Bloomington, ILNPI 1598247520

Payments from drug & device makers

$6,086in general payments, 2019–2025

Across 335 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$687
  • Aimmune Therapeutics, Inc.$606
  • Takeda Pharmaceuticals U.S.A., Inc.$508
  • Phathom Pharmaceuticals, Inc.$395
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$332
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$6,05599%
  • Education$311%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,086 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$232,464
Medicare patients
330
Services billed
10,462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin12$33,858
LinzessLinaclotide20$26,774
Colestipol Hcl89$3,724
Pantoprazole Sodium187$2,625
Sucralfate114$2,401
Cholestyramine LightCholestyramine17$1,818
Omeprazole140$1,752
Lansoprazole13$592
Dicyclomine Hcl39$494
Famotidine70$487
Esomeprazole Magnesium11$281
Ondansetron OdtOndansetron11$212
Promethazine Hcl15$153
Hydrocortisone14$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$332$33,85812 claims
AbbVieLinzess$2,060$26,77420 claims
SandozLansoprazole$57$59213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Bloomington

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →